{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T22:07:09Z","timestamp":1787695629203,"version":"build-2784847793"},"reference-count":30,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,8]],"date-time":"2025-04-08T00:00:00Z","timestamp":1744070400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100011699","name":"Siemens Healthineers","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011699","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007210","name":"Varian Medical Systems Inc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007210","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","redjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Radiation Oncology*Biology*Physics"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.ijrobp.2025.03.036","type":"journal-article","created":{"date-parts":[[2025,3,29]],"date-time":"2025-03-29T06:18:02Z","timestamp":1743229082000},"page":"721-728","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Reducing Number of Treatment Fractions for Patients With Abdominal Lymph Node Oligometastases: The Need for Online Adaptive Radiation Therapy to Provide Personalized Adaptive Fractionation"],"prefix":"10.1016","volume":"122","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-4218-3817","authenticated-orcid":false,"given":"Erik","family":"van Lieshout","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucy A.","family":"van Werkhoven","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mischa S.","family":"Hoogeman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Remi A.","family":"Nout","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maaike T.W.","family":"Milder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joost J.M.E.","family":"Nuyttens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijrobp.2025.03.036_bib0001","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1200\/JCO.1995.13.1.8","article-title":"Oligometastases","volume":"13","author":"Hellman","year":"1995","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2025.03.036_bib0002","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1038\/nrclinonc.2014.96","article-title":"The oligometastatic state - separating truth from wishful thinking","volume":"11","author":"Palma","year":"2014","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.ijrobp.2025.03.036_bib0003","doi-asserted-by":"crossref","first-page":"2830","DOI":"10.1200\/JCO.20.00818","article-title":"Stereotactic ablative radiotherapy for the comprehensive treatment of oligometastatic cancers: Long-term results of the sabr-comet phase II randomized trial","volume":"38","author":"Palma","year":"2020","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2025.03.036_bib0004","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1016\/S0140-6736(18)32487-5","article-title":"Stereotactic ablative radiotherapy versus standard of care palliative treatment in patients with oligometastatic cancers (SABR-COMET): A randomised, phase 2, open-label trial","volume":"393","author":"Palma","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.ijrobp.2025.03.036_bib0005","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/S1470-2045(20)30537-4","article-title":"Stereotactic ablative body radiotherapy in patients with oligometastatic cancers: A prospective, registry-based, single-arm, observational, evaluation study","volume":"22","author":"Chalkidou","year":"2021","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ijrobp.2025.03.036_bib0006","series-title":"Global cancer burden growing, amidst mounting need for services","year":"2024"},{"key":"10.1016\/j.ijrobp.2025.03.036_bib0007","doi-asserted-by":"crossref","DOI":"10.1136\/bmjgh-2022-009316","article-title":"The global health workforce stock and distribution in 2020 and 2030: A threat to equity and \u2018universal\u2019 health coverage?","volume":"7","author":"Boniol","year":"2022","journal-title":"BMJ Glob Health"},{"key":"10.1016\/j.ijrobp.2025.03.036_bib0008","doi-asserted-by":"crossref","first-page":"822","DOI":"10.2340\/1651-226X.2024.40681","article-title":"Stereotactic body radiation therapy on abdominal-pelvic lymph node oligometastases: A systematic review on toxicity","volume":"63","author":"van Werkhoven","year":"2024","journal-title":"Acta Oncol"},{"key":"10.1016\/j.ijrobp.2025.03.036_bib0009","doi-asserted-by":"crossref","first-page":"S1082","DOI":"10.1016\/S0167-8140(19)32403-X","article-title":"Inter and intra-fraction bowel motion during abdomino-pelvic stereotactic ablative radiotherapy","volume":"133","author":"Slevin","year":"2019","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2025.03.036_bib0010","doi-asserted-by":"crossref","first-page":"e644","DOI":"10.1016\/j.ijrobp.2023.06.2058","article-title":"Intra fraction organs at risk movements in adaptive radiotherapy of upper-abdominal stereotactic body radiotherapy on 0.35 T MR-linac","volume":"117","author":"Beige","year":"2023","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2025.03.036_bib0011","doi-asserted-by":"crossref","first-page":"3269","DOI":"10.1007\/s00432-021-03739-8","article-title":"Mitigation on bowel loops daily variations by 1.5-T MR-guided daily-adaptive SBRT for abdomino-pelvic lymph-nodal oligometastases","volume":"147","author":"Cuccia","year":"2021","journal-title":"J Cancer Res Clin Oncol"},{"key":"10.1016\/j.ijrobp.2025.03.036_bib0012","first-page":"46","article-title":"Individual lymph nodes: \u201cSee it and zap it\u201d","volume":"18","author":"Winkel","year":"2019","journal-title":"Clin Transl Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2025.03.036_bib0013","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.phro.2022.06.011","article-title":"Impact of magnetic resonance-guided versus conventional radiotherapy workflows on organ at risk doses in stereotactic body radiotherapy for lymph node oligometastases","volume":"23","author":"Werensteijn-Honingh","year":"2022","journal-title":"Phys Imaging Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2025.03.036_bib0014","doi-asserted-by":"crossref","DOI":"10.2340\/1651-226X.2024.40681","article-title":"Results of a single-arm phase 2 clinical trial: Online adaptive stereotactic body radiation therapy for abdominal-pelvic oligometastases","author":"van Werkhoven","year":"2024","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2025.03.036_bib0015","doi-asserted-by":"crossref","first-page":"4816","DOI":"10.1002\/mp.12432","article-title":"Cyberknife with integrated ct-on-rails: System description and first clinical application for pancreas sbrt","volume":"44","author":"Papalazarou","year":"2017","journal-title":"Med Phys"},{"key":"10.1016\/j.ijrobp.2025.03.036_bib0016","doi-asserted-by":"crossref","first-page":"4078","DOI":"10.1118\/1.3438081","article-title":"Stereotactic body radiation therapy: The report of AAPM Task Group 101","volume":"37","author":"Benedict","year":"2010","journal-title":"Med Phys"},{"key":"10.1016\/j.ijrobp.2025.03.036_bib0017","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1016\/j.ijrobp.2022.06.078","article-title":"In silico trial of computed tomography-guided stereotactic adaptive radiation therapy (CT-STAR) for the treatment of abdominal oligometastases","volume":"114","author":"Schiff","year":"2022","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2025.03.036_bib0018","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1016\/j.ijrobp.2022.05.016","article-title":"Stereotactic magnetic resonance-guided adaptive radiation therapy (SMART) for abdominopelvic oligometastases","volume":"114","author":"Yang","year":"2022","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2025.03.036_bib0019","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.radonc.2020.02.011","article-title":"Target coverage and dose criteria based evaluation of the first clinical 1.5T MR-linac SBRT treatments of lymph node oligometastases compared with conventional CBCT-linac treatment","volume":"146","author":"Winkel","year":"2020","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2025.03.036_bib0020","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.radonc.2022.01.038","article-title":"Smart ablation of lymphatic oligometastases in the pelvis and abdomen: Clinical and dosimetry outcomes","volume":"168","author":"Regnery","year":"2022","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2025.03.036_bib0021","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1016\/j.ijrobp.2016.08.036","article-title":"Simulated online adaptive magnetic resonance-guided stereotactic body radiation therapy for the treatment of oligometastatic disease of the abdomen and central thorax: Characterization of potential advantages","volume":"96","author":"Henke","year":"2016","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2025.03.036_bib0022","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.radonc.2017.11.032","article-title":"Phase I trial of stereotactic MR-guided online adaptive radiation therapy (SMART) for the treatment of oligometastatic or unresectable primary malignancies of the abdomen","volume":"126","author":"Henke","year":"2018","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2025.03.036_bib0023","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1159\/000491605","article-title":"Single-fraction stereotactic body radiotherapy for oligometastatic lymph node relapse in prostate cancer","volume":"41","author":"Loi","year":"2018","journal-title":"Oncol Res Treat"},{"key":"10.1016\/j.ijrobp.2025.03.036_bib0024","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1007\/s00066-021-01834-w","article-title":"Stereotactic body radiotherapy of lymph node metastases under MR-guidance: First clinical results and patient-reported outcomes","volume":"198","author":"Weykamp","year":"2022","journal-title":"Strahlenther Onkol"},{"key":"10.1016\/j.ijrobp.2025.03.036_bib0025","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1016\/j.ijrobp.2020.10.011","article-title":"Safety, efficacy, and patterns of failure after single-fraction stereotactic body radiation therapy (SBRT) for oligometastases","volume":"109","author":"Sogono","year":"2021","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2025.03.036_bib0026","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1080\/0284186X.2021.1982145","article-title":"Dose summation and image registration strategies for radiobiologically and anatomically corrected dose accumulation in pelvic re-irradiation","volume":"61","author":"Nix","year":"2022","journal-title":"Acta Oncol"},{"key":"10.1016\/j.ijrobp.2025.03.036_bib0027","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1186\/s13014-023-02284-7","article-title":"Comparison of different dose accumulation strategies to estimate organ doses after stereotactic magnetic resonance-guided adaptive radiotherapy","volume":"18","author":"Regnery","year":"2023","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2025.03.036_bib0028","doi-asserted-by":"crossref","first-page":"S59","DOI":"10.1016\/j.brachy.2015.02.296","article-title":"The role of deformable image registration looking at small bowel and sigmoid during multi-fraction adaptive image-guided HDR brachytherapy for cervix cancer","volume":"14","author":"Bachand","year":"2015","journal-title":"Brachytherapy"},{"key":"10.1016\/j.ijrobp.2025.03.036_bib0029","doi-asserted-by":"crossref","first-page":"3426","DOI":"10.1118\/1.4955993","article-title":"Su-f-j-85: Evaluation of the velocity deformable image registration algorithm","volume":"43","author":"Polan","year":"2016","journal-title":"Med Phys"},{"key":"10.1016\/j.ijrobp.2025.03.036_bib0030","doi-asserted-by":"crossref","first-page":"e43","DOI":"10.1002\/mp.12256","article-title":"Use of image registration and fusion algorithms and techniques in radiotherapy: Report of the AAPM Radiation Therapy Committee Task Group No. 132","volume":"44","author":"Brock","year":"2017","journal-title":"Med Phys"}],"container-title":["International Journal of Radiation Oncology*Biology*Physics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301625002676?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301625002676?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,6]],"date-time":"2025-06-06T05:23:43Z","timestamp":1749187423000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0360301625002676"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":30,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["S0360301625002676"],"URL":"https:\/\/doi.org\/10.1016\/j.ijrobp.2025.03.036","relation":{},"ISSN":["0360-3016"],"issn-type":[{"value":"0360-3016","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Reducing Number of Treatment Fractions for Patients With Abdominal Lymph Node Oligometastases: The Need for Online Adaptive Radiation Therapy to Provide Personalized Adaptive Fractionation","name":"articletitle","label":"Article Title"},{"value":"International Journal of Radiation Oncology*Biology*Physics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijrobp.2025.03.036","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}